Filing Flows › Verastem (VSTM) › Q1 2026
Verastem (VSTM) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Verastem (VSTM) reported revenue of $18.7M for the first quarter 2026 (Q1 2026) and +6% from the quarter before. Operating margin was -240.5%, net loss $36.6M (196.0% of revenue).
Verastem, Q1 2026: revenue $18.7M, operating margin -240.5%, net loss $36.6M, operating cash flow −$52.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.7M | +6% | — |
| Operating profit | −$44.9M | — | — |
| Net earnings | −$36.6M | — | — |
| Operating cash flow | −$52.1M | — | — |
What changed
Revenue was $18.7M in Q1 2026, up 6% from the previous quarter.
Operating costs exceeded revenue by $44.9M, an operating margin of -240.5%. The quarter ended with a net loss of $36.6M, wider than the previous quarter's $32.9M loss. Non-operating items added $8.3M, -23% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$52.1M. Non-cash charges added back $2.0M of share-based compensation. Working capital and other items used $17.6M.
Questions
What was Verastem's revenue in the first quarter 2026?
Verastem (VSTM) reported revenue of $18.7M for the first quarter 2026 (Q1 2026) and +6% from the quarter before.
Was Verastem profitable in the first quarter 2026?
Operating loss was $44.9M (-240.5% of revenue) and net loss $36.6M.
Source: Verastem 10-Q on SEC EDGAR.